Company news

Bioventus Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago

October 11, 2022

Bioventus to Present at the Morgan Stanley Global Healthcare Conference

August 29, 2022

Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

August 10, 2022

Bioventus Receives FDA 510(k) Clearance for SonaStar Elite

August 2, 2022

Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

July 25, 2022

Bioventus Completes CartiHeal Acquisition

July 11, 2022

Bioventus Amends CartiHeal Acquisition Structure

June 20, 2022

Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance

May 9, 2022

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

May 2, 2022

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

May 1, 2022

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

April 25, 2022

Bioventus Announces $415 Million Offering of Senior Notes

April 25, 2022

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

April 24, 2022

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

April 7, 2022

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

April 4, 2022

Bioventus Exercises Call Option to Acquire CartiHeal

April 3, 2022

Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference

March 15, 2022

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

March 9, 2022

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

February 28, 2022

Bioventus Appoints Mark Singleton as Chief Financial Officer

February 27, 2022

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

February 21, 2022

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

January 10, 2022

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

December 27, 2021

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

December 20, 2021

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

December 19, 2021

Bioventus to Expand Operations and Manufacturing in Memphis

November 17, 2021

Bioventus Announces Chief Financial Officer Transition Plan

November 14, 2021

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

November 8, 2021

Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs

October 31, 2021

Bioventus Completes the Acquisition of Misonix

October 28, 2021

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

October 26, 2021

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

October 25, 2021

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5: 00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

October 17, 2021

DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons

September 19, 2021

Bioventus Proceeds with Option Structure Agreement with CartiHeal

August 29, 2021

Bioventus Invests in Trice Medical Minimally Invasive Technologies

August 24, 2021

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

August 22, 2021

Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance

August 9, 2021

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

July 28, 2021

Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix

July 28, 2021

Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference

July 26, 2021

Bioventus Appoints Mary Kay Ladone to Board of Directors

July 13, 2021

Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide

July 12, 2021

Bioventus Invests in Vaporox

June 23, 2021

Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021

June 15, 2021

Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance

May 11, 2021

Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System

April 26, 2021

Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

April 11, 2021

Bioventus Acquires Bioness, Inc.

March 29, 2021

Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance

March 24, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 33 decks. Every deck is listed under its year.